Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Allen D Roses of GlaxoSmithKline to Present at GTCbio`s Targeted Designs for Clinical Trials Conference (July 19-20, Philadelphia, PA)

Released on = June 18, 2007, 5:23 pm

Press Release Author = GTCbio

Industry = Pharmaceuticals

Press Release Summary = MONROVIA, CA – Allen D, Roses, Senior Vice President of
Pharmacogenetics for GlaxoSmithKline, will deliver the keynote addresses at GTCbio’s
Targeted Designs for Clinical Trials Conference taking place in Philadelphia, PA on
July 19-20, 2007. Dr. Roses is a renowned expert on genetics research. He joined
GlaxoSmithKline from Duke University in 1997. While at Duke, he led the team that
reported susceptibility association of APOE4 with late-onset Alzheimer disease.


Press Release Body = MONROVIA, CA – Allen D, Roses, Senior Vice President of
Pharmacogenetics for GlaxoSmithKline, will deliver the keynote addresses at GTCbio’s
Targeted Designs for Clinical Trials Conference taking place in Philadelphia, PA on
July 19-20, 2007. Dr. Roses is a renowned expert on genetics research. He joined
GlaxoSmithKline from Duke University in 1997. While at Duke, he led the team that
reported susceptibility association of APOE4 with late-onset Alzheimer disease.

Dr. Roses’ presentation entitled, “New Opportunities to Bring Drugs and
Pharmacogenetics into the Clinic” will take place at 3:30 am on July 19, 2007.

GTCbio’s Targeted Designs for Clinical Trials Conference addresses strategies to
accelerate drug development, lower trial costs and reduce development risks. The
conference will also feature presentations from AstraZeneca Pharmaceuticals, Aureon
Biosciences Corporation, BioImaging Technologies, H. Lee Moffit Cancer Center,
Johnson & Johnson PRD, Kendle International, Merck Research Laboratories, Roche
Diagnostics, PDL BioPharma, Pfizer, PPD, St. Jude Children\'s Research Hospital,
Tessella, University of Cincinnati College of Pharmacy, Vanderbilt University School
of Medicine, Virginia Commonwealth University, Wolf, Greenfield & Sacks, P.C., Wyeth
Research and more.

For more information including a detailed agenda, exhibitor opportunities and
registration information visit
http://www.gtcbio.com/conference/conferenceDetails.aspx?id

Web Site = http://www.gtcbio.com

Contact Details = ABOUT GTCbio

GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, christy.bowman@gtcbio.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •